ALLENA PHARMACEUTICALS INC (ALNA)
US0181191075 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -43.30M | -48.66M | -32.85M | -47.34M | -35.65M | |||
| Depreciation Amortization | 461.00K | 363.00K | 170.00K | 160.00K | 80.00K | |||
| Change In Working Capital | -10.90M | -1.48M | -160.00K | 60.00K | 900.00K | |||
| Interest Paid | N/A | 953.00K | 360.00K | 540.00K | 910.00K | |||
| Other non cash items | 4.87M | 4.11M | 4.68M | 3.48M | 2.83M | |||
| OPERATING CASH FLOW | -48.87M | -45.68M | -28.16M | -43.63M | -31.84M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -210.00K | -667.00K | -650.00K | -120.00K | -320.00K | |||
| Other Investing Activity | N/A | 0.00 | 20.00K | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | -210.00K | -667.00K | -630.00K | -120.00K | -320.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.00M | 0.00 | 0.00 | 0.00 | -490.00K | |||
| Stock Issued/Repurchased | 34.02M | 41.29M | 34.06M | 12.15M | -140.00K | |||
| Other Financing Activity | N/A | 0.00 | -240.00K | -30.00K | -70.00K | |||
| FINANCING CASH FLOW | 29.02M | 41.29M | 33.83M | 12.12M | -690.00K | |||
| CHANGE IN CASH | -20.07M | -5.05M | 5.04M | -31.63M | -32.85M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -48.87M | -45.68M | -28.16M | -43.63M | -31.84M | |||
| Capital Expenditure | -210.00K | -667.00K | -650.00K | -120.00K | -320.00K | |||
| FREE CASH FLOW | -49.08M | -46.34M | -28.81M | -43.75M | -32.16M | |||
All data in USD